PPAR alpha, fibrates, lipid metabolism and inflammation.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Archives des maladies du coeur et des vaisseaux

• Publication date

  2004-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 15283041
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of cholesterol absorption associated with a PPAR alpha-dependent increase in ABC binding cassette transporter A1 in mice.

  2003cited by this paper
• Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux.

  2003cited by this paper
• The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-α and Contains a Novel Farnesoid X-activated Receptor Response Element*

  2003cited by this paper
• Peroxisome Proliferator-Activated Receptor &agr; Reduces Cholesterol Esterification in Macrophages

  2003cited by this paper
• PPAR(alpha) and PPAR(gamma) activators suppress the monocyte-macrophage apoB-48 receptor.

  2003cited by this paper
• Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation.

  2003cited by this paper
• Control of human carnitine palmitoyltransferase II gene transcription by peroxisome proliferator-activated receptor through a partially conserved peroxisome proliferator-responsive element.

  2003cited by this paper
• Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.

  2003cited by this paper
• Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.

  2003cited by this paper
• Functional interference between estrogen-related receptor alpha and peroxisome proliferator-activated receptor alpha/9-cis-retinoic acid receptor alpha heterodimer complex in the nuclear receptor response element-1 of the medium chain acyl-coenzyme A dehydrogenase gene.

  2003cited by this paper
• Peroxisome proliferator-activated receptor α induces rat sterol carrier protein x promoter activity through two peroxisome proliferator-response elements

  2003cited by this paper
• Fibrates Down-regulate Hepatic Scavenger Receptor Class B Type I Protein Expression in Mice*

  2003cited by this paper
• Apolipoprotein A5, a Crucial Determinant of Plasma Triglyceride Levels, Is Highly Responsive to Peroxisome Proliferator-activated Receptor α Activators*

  2003cited by this paper
• PPARalpha inhibits TGF-beta-induced beta5 integrin transcription in vascular smooth muscle cells by interacting with Smad4.

  2002cited by this paper
• Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent.

  2002cited by this paper
• Regulation and mechanisms of macrophage cholesterol efflux.

  2002cited by this paper
• Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial.

  2002cited by this paper
• Peroxisome proliferator‐activated receptor (PPAR) agonists decrease lipoprotein lipase secretion and glycated LDL uptake by human macrophages

  2002cited by this paper
• Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor alpha and gamma ligands.

  2002cited by this paper
• PPAR Activators as Antiinflammatory Mediators in Human T Lymphocytes: Implications for Atherosclerosis and Transplantation-Associated Arteriosclerosis

  2002cited by this paper
• Apolipoprotein A-II, HDL metabolism and atherosclerosis.

  2002cited by this paper
• Influence of Peroxisome Proliferator-activated Receptor α Agonists on the Intracellular Turnover and Secretion of Apolipoprotein (Apo) B-100 and ApoB-48*

  2002cited by this paper
• Identification of a subtype selective human PPARalpha agonist through parallel-array synthesis.

  2001cited by this paper
• Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.

  2001cited by this paper
• Direct regulatory effect of fatty acids on macrophage lipoprotein lipase: potential role of PPARs.

  2001cited by this paper
• Regulation of liver carnitine palmitoyltransferase I gene expression by hormones and fatty acids.

  2001cited by this paper
• Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine.

  2001cited by this paper
• Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta.

  2001cited by this paper
• Induction of the Phospholipid Transfer Protein Gene Accounts for the High Density Lipoprotein Enlargement in Mice Treated with Fenofibrate*

  2001cited by this paper
• Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha).

  2001cited by this paper
• Lipoprotein lipase mediates the uptake of glycated LDL in fibroblasts, endothelial cells, and macrophages.

  2001cited by this paper
• Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus.

  2001cited by this paper
• Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.

  2001cited by this paper
• Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathway.

  2001cited by this paper
• PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.

  2000cited by this paper
• Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription.

  2000cited by this paper
• Decreased Susceptibility to Diet-Induced Atherosclerosis in Human Apolipoprotein A-II Transgenic Mice

  2000cited by this paper
• The PPARs: from orphan receptors to drug discovery.

  2000cited by this paper
• Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators.

  2000cited by this paper
• Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha.

  2000cited by this paper
• The effect of peroxisome-proliferator-activated receptor-alpha on the activity of the cholesterol 7 alpha-hydroxylase gene.

  2000cited by this paper
• Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner.

  2000cited by this paper
• Ligand-dependent interaction of hepatic fatty acid-binding protein with the nucleus.

  2000cited by this paper
• Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation

  2000cited by this paper
• CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors.

  2000cited by this paper
• The Murine and Human Cholesterol 7α-Hydroxylase Gene Promoters Are Differentially Responsive to Regulation by Fatty Acids Mediated via Peroxisome Proliferator-activated Receptor α*

  2000cited by this paper
• Lipoprotein lipase, a key role in atherosclerosis?

  1999cited by this paper
• Peroxisome proliferator-activated receptors: nuclear control of metabolism.

  1999cited by this paper
• Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPARalpha) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated by stat5b.

  1999cited by this paper
• Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction.

  1999cited by this paper
• Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway.

  1999cited by this paper
• Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1*

  1999cited by this paper
• PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells.

  1999cited by this paper
• Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

  1998cited by this paper
• Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner.

  1998cited by this paper
• Peroxisome Proliferator-activated Receptor α Activation Modulates Cellular Redox Status, Represses Nuclear Factor-κB Signaling, and Reduces Inflammatory Cytokine Production in Aging*

  1998cited by this paper
• Mechanism of action of fibrates on lipid and lipoprotein metabolism.

  1998cited by this paper
• Activation of Proliferator-activated Receptors α and γ Induces Apoptosis of Human Monocyte-derived Macrophages*

  1998cited by this paper
• Co-regulation of Tissue-specific Alternative Human Carnitine Palmitoyltransferase Iβ Gene Promoters by Fatty Acid Enzyme Substrate*

  1998cited by this paper
• Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb.

  1998cited by this paper
• Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells.

  1998cited by this paper
• The Nuclear Receptors Peroxisome Proliferator-activated Receptor α and Rev-erbα Mediate the Species-specific Regulation of Apolipoprotein A-I Expression by Fibrates*

  1998cited by this paper
• DNA Binding Properties of Peroxisome Proliferator-activated Receptor Subtypes on Various Natural Peroxisome Proliferator Response Elements

  1997cited by this paper
• Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway*

  1997cited by this paper
• Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta.

  1997cited by this paper
• Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma.

  1997cited by this paper
• PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene.

  1996cited by this paper
• Pharmacodynamic activity of lipoprotein lipase and hepatic lipase, and pharmacokinetic parameters measured in normolipidaemic subjects receiving ciprofibrate (100 or 200 mg/day) or micronised fenofibrate (200 mg/day) therapy for 23 days.

  1996cited by this paper
• Effects of different phenotypes of hyperlipoproteinemia and of treatment with fibric acid derivatives on the rates of cholesterol 7 alpha-hydroxylation in humans.

  1995cited by this paper
• Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: Reduced activity of cholesterol 7α‐hydroxylase

  1995cited by this paper
• Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.

  1995cited by this paper
• Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids.

  1994cited by this paper
• Plasma cholesteryl ester transfer protein.

  1993cited by this paper
• Transcriptional induction of the fatty acid binding protein gene in mouse liver by bezafibrate

  1993cited by this paper
• Down-regulation of hepatic lipase gene expression and activity by fenofibrate.

  1992cited by this paper
• Lecithin:cholesterol acyltransferase gene expression is regulated in a tissue-selective manner by fibrates.

  1992cited by this paper
• Effects of treatment with clofibrate, bezafibrate, and ciprofibrate on the metabolism of cholesterol in rat liver microsomes.

  1989cited by this paper
• Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis.

  1987cited by this paper
• High density lipoprotein metabolism.

  1984cited by this paper

• MicroRNA-21: A critical underestimated molecule in Diabetic Retinopathy.

  2023cites this paper
• Molecular cytogenetic and phenotypic characterization of Phelan McDermid and 22q13 duplication syndrome: a case report

  2022cites this paper
• Phenolic Acids from Fructus Chebulae Immaturus Alleviate Intestinal Ischemia-Reperfusion Injury in Mice through the PPARα/NF-κB Pathway

  2022cites this paper
• Liver injury after small bowel resection is prevented in obesity-resistant 129S1/SvImJ mice.

  2021cites this paper
• A Potential Endurance Algorithm Prediction in the Field of Sports Performance

  2020cites this paper
• Heat Stress-Responsive Transcriptome Analysis in the Liver Tissue of Hu Sheep

  2019cites this paper
• Regulatory T Cell Metabolism in the Hepatic Microenvironment

  2018cites this paper
• Dietary Genistein Alleviates Lipid Metabolism Disorder and Inflammatory Response in Laying Hens With Fatty Liver Syndrome

  2018cites this paper
• Glucose and lipid metabolism disorders in the chickens with dexamethasone‐induced oxidative stress

  2018cites this paper
• Opposing Effects of PPARα Agonism and Antagonism on Refractive Development and Form Deprivation Myopia in Guinea Pigs.

  2018cites this paper
• The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α

  2017cites this paper
• Pathogenic Role of microRNA-21 in Diabetic Retinopathy Through Downregulation of PPARα

  2017cites this paper
• Ursolic acid prevents augmented peripheral inflammation and inflammatory hyperalgesia in high-fat diet-induced obese rats by restoring downregulated spinal PPARα.

  2016cites this paper
• Peroxisome proliferator-activated receptors (PPAR) downregulate the expression of pro-inflammatory molecules in an experimental model of myocardial infarction.

  2016cites this paper
• The update on transcriptional regulation of autophagy in normal and pathologic cells: A novel therapeutic target.

  2015cites this paper
• Fibrates and cholestasis

  2015cites this paper
• Immuno-detection of PPAR overexpression with no change protein turnover endocardial tissues suggests major alterations in energy metabolism during ischemic and dilated cardiomyopathy conditions of heart

  2015influential citation
• Orphan drugs in development for primary biliary cirrhosis: challenges and progress

  2015cites this paper
• Down-regulation of PPARα in the spinal cord contributes to augmented peripheral inflammation and inflammatory hyperalgesia in diet-induced obese rats.

  2014cites this paper
• Transcriptional regulation of the human, porcine and bovine OCTN2 gene by PPARα via a conserved PPRE located in intron 1

  2014cites this paper
• Eriocitrin ameliorates diet-induced hepatic steatosis with activation of mitochondrial biogenesis

  2014cites this paper
• The roles of peroxisome proliferator-activated receptors in the metabolic syndrome.

  2014cites this paper
• Obesity and Increased Risk for Atherosclerosis and Cancer

  2014cites this paper
• The Roles of PPARs in the Metabolic Syndrome Basic understanding of lipids and carbohydrates metabolism

  2013cites this paper
• Ameliorative potential of gemfibrozil and silymarin on experimentally induced nephrotoxicity in rats

  2013cites this paper
• Impact of fatty acids on human UDP-glucuronosyltransferase 1A1 activity and its expression in neonatal hyperbilirubinemia

  2013cites this paper
• Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction

  2013cites this paper
• Effects of DEHP in the Liver: Modes of Action and Species-Specific Differences

  2009cites this paper
• Non-alcoholic steatohepatitis : second hit or strike out?

  2008cites this paper
• Neurological Recovery-Promoting, Anti-Inflammatory, and Anti-Oxidative Effects Afforded by Fenofibrate, a PPAR Alpha Agonist, in Traumatic Brain Injury

  2007cites this paper
• Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation

  2007cites this paper
• Pseudomonas aeruginosa and sPLA2 IB stimulate ABCA1-mediated phospholipid efflux via ERK-activation of PPARalpha-RXR.

  2007cites this paper
• PPARs, síndrome metabólico y enfermedad cardíaca.

  2007cites this paper
• Modes of Action and Species-Specific Effects of Di-(2-ethylhexyl)Phthalate in the Liver

  2006cites this paper
• The role of PPARδ in the diabetic cardiomyopathy

  2006cites this paper
• Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates.

  2006cites this paper
• Elevated Homocysteine Reduces Apolipoprotein A-I Expression in Hyperhomocysteinemic Mice and in Males With Coronary Artery Disease

  2006cites this paper
• The selected pathophysiological aspects of PPARs activation.

  2005cites this paper
• Ligands to peroxisome proliferator-activated receptors as therapeutic options for metabolic syndrome

  2005cites this paper
• The Era of Statins – Is There Still a Place for Other Classes of Lipid-Lowering Drugs?

  2005cites this paper
• Downregulation of peroxisome proliferator-activated receptors (PPARs) in nasal polyposis

  2005cites this paper
• Selective expression of a dominant-negative form of peroxisome proliferator-activated receptor in keratinocytes leads to impaired epidermal healing.

  2005cites this paper
• Oczyszczanie białka wiążącego kwasy tłuszczowe z wątroby ludzkiej : otrzymywanie specyficznych przeciwciał przeciwko temu białku i ich zastosowanie w metodzie ELISA

  2005cites this paper
• A new retinoid-like compound that activates peroxisome proliferator-activated receptors and lowers blood glucose in diabetic mice.

  2005cites this paper
• Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.

  2005cites this paper